These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 6089443
1. [Experimental and clinical experiences with steroid hormone receptors in breast cancer]. Jonat W. Wien Klin Wochenschr; 1984 Jun 22; 96(13):499-508. PubMed ID: 6089443 [Abstract] [Full Text] [Related]
2. [Hormonreceptors in the therapy concept of breast cancer (author's transl)]. Jonat W, Maass H. Arch Geschwulstforsch; 1981 Jun 22; 51(7):637-41. PubMed ID: 7337546 [Abstract] [Full Text] [Related]
3. [Determination of estrogen and progesterone receptors in cancer of the breast. Frequency of presentation and prognostic significance]. Expósito J, Olea N, Ruiz de Almodovar JM, Pedraza V. Rev Esp Oncol; 1985 Jun 22; 32(3):471-85. PubMed ID: 3870538 [Abstract] [Full Text] [Related]
4. [Place of hormone receptor determination in the therapeutic strategy of breast cancer]. Clavel B, Gest J. Pathol Biol (Paris); 1983 Dec 22; 31(10):809-18. PubMed ID: 6366702 [Abstract] [Full Text] [Related]
5. Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO. J Clin Oncol; 2007 Oct 20; 25(30):4772-8. PubMed ID: 17876012 [Abstract] [Full Text] [Related]
6. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors. Brouckaert O, Pintens S, Van Belle V, Van Huffel S, Camerlynck E, Amant F, Leunen K, Smeets A, Berteloot P, Van Limbergen E, Decock J, Hendrickx W, Weltens C, Van den Bogaert W, Vanden Bempt I, Drijkoningen M, Paridaens R, Wildiers H, Vergote I, Christiaens MR, Neven P. Breast Cancer Res Treat; 2009 May 20; 115(2):349-58. PubMed ID: 18629635 [Abstract] [Full Text] [Related]
7. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction. Nesković-Konstantinović ZB, Nikolić-Vukosavljević DB, Branković-Magić MV, Mitrovic LB, Spuzić I. Neoplasma; 2000 May 20; 47(2):107-13. PubMed ID: 10985476 [Abstract] [Full Text] [Related]
8. [Experimental and clinical aspects of hormone therapy in breast cancer (author's transl)]. Maass H, Jonat W. Arch Geschwulstforsch; 1981 May 20; 51(7):623-9. PubMed ID: 7337544 [Abstract] [Full Text] [Related]
9. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA. Anticancer Res; 2004 May 20; 24(4):2391-400. PubMed ID: 15330189 [Abstract] [Full Text] [Related]
10. [Steroid hormone receptors in breast cancer (a review of the literature)]. Korolev VI, Dziubko NIa, Tarutinov VI. Vrach Delo; 1988 Nov 20; (11):86-91. PubMed ID: 2853492 [No Abstract] [Full Text] [Related]
11. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer. Foekens JA, Diamandis EP, Yu H, Look MP, Meijer-van Gelder ME, van Putten WL, Klijn JG. Br J Cancer; 1999 Feb 20; 79(5-6):888-94. PubMed ID: 10070886 [Abstract] [Full Text] [Related]
12. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy. Takei H, Horiguchi J, Maemura M, Koibuchi Y, Oyama T, Yokoe T, Iino Y, Morishita Y. Oncol Rep; 2002 Feb 20; 9(2):375-8. PubMed ID: 11836611 [Abstract] [Full Text] [Related]
13. [Adjuvant endocrine forms of therapy in breast cancer]. Jakesz R, Hausmaninger H. Wien Klin Wochenschr; 1984 Jun 22; 96(13):492-9. PubMed ID: 6475078 [Abstract] [Full Text] [Related]
14. [Hormone dependence and the basis of hormone therapy in breast cancer]. Martin PM. J Gynecol Obstet Biol Reprod (Paris); 1978 Mar 22; 7(2):183-99. PubMed ID: 209076 [No Abstract] [Full Text] [Related]
15. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination. Yu H, Levesque MA, Clark GM, Diamandis EP. Br J Cancer; 1999 Oct 22; 81(3):490-5. PubMed ID: 10507775 [Abstract] [Full Text] [Related]
16. Steroid receptors in human breast cancer. McGuire WL. Cancer Res; 1978 Nov 22; 38(11 Pt 2):4289-91. PubMed ID: 698967 [Abstract] [Full Text] [Related]
17. Steroid hormone receptors in the management of human breast cancer. Knight WA, Osborne CK, Yochmowitz MG, McGuire WL. Ann Clin Res; 1980 Oct 22; 12(5):202-7. PubMed ID: 7015982 [Abstract] [Full Text] [Related]
18. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands]. Voogd AC, Crommelin MA, Repelaer van Driel OJ, Tutein Nolthenius-Puylaert MC, Vreugdenhil G, Coebergh JW. Ned Tijdschr Geneeskd; 1998 Aug 01; 142(31):1772-8. PubMed ID: 9856143 [Abstract] [Full Text] [Related]
19. Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. Millar EK, Graham PH, O'Toole SA, McNeil CM, Browne L, Morey AL, Eggleton S, Beretov J, Theocharous C, Capp A, Nasser E, Kearsley JH, Delaney G, Papadatos G, Fox C, Sutherland RL. J Clin Oncol; 2009 Oct 01; 27(28):4701-8. PubMed ID: 19720911 [Abstract] [Full Text] [Related]
20. Does estrogen receptor negative/progesterone receptor positive breast carcinoma exist? De Maeyer L, Van Limbergen E, De Nys K, Moerman P, Pochet N, Hendrickx W, Wildiers H, Paridaens R, Smeets A, Christiaens MR, Vergote I, Leunen K, Amant F, Neven P. J Clin Oncol; 2008 Jan 10; 26(2):335-6; author reply 336-8. PubMed ID: 18182677 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]